Trinity Biotech PLC reports results for the quarter ended September 30 - Earnings Summary

Reuters11-15

Trinity Biotech <a href="https://laohu8.com/S/PLC">PLC</a> reports results for the quarter ended September 30 - Earnings Summary

Trinity Biotech PLC TRIB.OQ reported a quarterly adjusted loss of 46 cents per share for the quarter ended September 30. The lone analyst forecast for the quarter was for a loss of 54 cents per share.
Revenue rose 3.2% to $15.15 million from a year ago; analysts expected $16.50 million.
Trinity Biotech PLC's reported EPS for the quarter was a loss of 46 cents.
Trinity Biotech PLC shares had risen by 34.5% this quarter and lost 31.0% so far this year.

FORECAST CHANGES

The mean earnings estimate of analysts had risen by about 1.8% in the last three months.
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

This summary was machine generated from LSEG data November 15 at 02:31 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING	ESTIMATE	ACTUAL	BEAT, MET, MISSED
Sep. 30 2024	-0.54	-0.46	Beat
Jun. 30 2024	-0.65	-0.71	Missed

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2483747593?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-15 22:31","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2483747593","market":"us","top_or_hot":-1,"title":"Trinity Biotech PLC reports results for the quarter ended September 30 - Earnings Summary","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>Trinity Biotech <a href=\"https://laohu8.com/S/PLC\">PLC</a> reports results for the quarter ended September 30 - Earnings Summary</title></head><body><ul><li><p>Trinity Biotech PLC <span>TRIB.OQ</span> reported a quarterly adjusted loss of 46 cents per share for the quarter ended September 30.  The lone analyst forecast for the quarter was for a loss of 54 cents per share. </p></li><li><p>Revenue rose 3.2% to $15.15 million from a year ago; analysts expected $16.50 million. </p></li><li><p>Trinity Biotech PLC's reported EPS for the quarter was a loss of 46 cents.</p></li><li><p>Trinity Biotech PLC shares had risen by 34.5% this quarter and lost 31.0% so far this year.</p></li></ul><p>FORECAST CHANGES</p><ul><li><p>The mean earnings estimate of analysts had risen by about 1.8% in the last three months. </p></li><li><p>In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.</p></li></ul><p>RECOMMENDATIONS</p><ul><li></li></ul><p>This summary was machine generated from LSEG data November 15 at 02:31 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)</p><table><tbody><tr><td><p>QUARTER ENDING</p></td><td><p>ESTIMATE </p></td><td><p>ACTUAL</p></td><td><p>BEAT, MET, MISSED</p></td></tr><tr><td><p>Sep. 30 2024 </p></td><td><p>-0.54</p></td><td><p>-0.46</p></td><td><p>Beat</p></td></tr><tr><td><p>Jun. 30 2024 </p></td><td><p>-0.65</p></td><td><p>-0.71</p></td><td><p>Missed</p></td></tr></tbody></table></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Trinity Biotech PLC reports results for the quarter ended September 30 - Earnings Summary</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTrinity Biotech PLC reports results for the quarter ended September 30 - Earnings Summary\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-15 22:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241115:nL8N3MM1FF:1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Trinity Biotech PLC reports results for the quarter ended September 30 - Earnings SummaryTrinity Biotech PLC TRIB.OQ reported a quarterly adjusted loss of 46 cents per share for the quarter ended ...</p>\n\n<a href=\"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241115:nL8N3MM1FF:1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TRIB","symbol_name":"Trinity Biotech plc","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241115:nL8N3MM1FF:1","article_id":"2483747593","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2483747593","pubTimestamp":1731681095,"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Trinity Biotech PLC reports results for the quarter ended September 30 - Earnings SummaryTrinity Biotech PLC TRIB.OQ reported a quarterly adjusted loss of 46 cents per share for the quarter ended Sept","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"TRIB":"Trinity Biotech plc"},"translate_title":"Trinity Biotech PLC报告截至9月30日的季度业绩-收益摘要","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TRIB":0.9},"content_text":"Trinity Biotech PLC reports results for the quarter ended September 30 - Earnings SummaryTrinity Biotech PLC TRIB.OQ reported a quarterly adjusted loss of 46 cents per share for the quarter ended September 30.  The lone analyst forecast for the quarter was for a loss of 54 cents per share. Revenue rose 3.2% to $15.15 million from a year ago; analysts expected $16.50 million. Trinity Biotech PLC's reported EPS for the quarter was a loss of 46 cents.Trinity Biotech PLC shares had risen by 34.5% this quarter and lost 31.0% so far this year.FORECAST CHANGESThe mean earnings estimate of analysts had risen by about 1.8% in the last three months. In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.RECOMMENDATIONSThis summary was machine generated from LSEG data November 15 at 02:31 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)QUARTER ENDINGESTIMATE ACTUALBEAT, MET, MISSEDSep. 30 2024 -0.54-0.46BeatJun. 30 2024 -0.65-0.71Missed","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2483747593"}